213 related articles for article (PubMed ID: 23027626)
21. ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells.
Rodgers JJ; McClure R; Epis MR; Cohen RJ; Leedman PJ; Harvey JM; ; Thomas MA; Bentel JM
J Cell Biochem; 2019 Jan; 120(1):848-860. PubMed ID: 30161276
[TBL] [Abstract][Full Text] [Related]
22. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor.
Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA
Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696
[TBL] [Abstract][Full Text] [Related]
23. Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis.
Li Y; Yang J; Dai C; Wu C; Liu Y
J Clin Invest; 2003 Aug; 112(4):503-16. PubMed ID: 12925691
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis.
Li Y; Tan X; Dai C; Stolz DB; Wang D; Liu Y
J Am Soc Nephrol; 2009 Sep; 20(9):1907-18. PubMed ID: 19541809
[TBL] [Abstract][Full Text] [Related]
25. Expression of EMT inducers integrin-linked kinase (ILK) and ZEB1 in phyllodes breast tumors is associated with aggressive phenotype.
Akrida I; Nikou S; Gyftopoulos K; Argentou M; Kounelis S; Zolota V; Bravou V; Papadaki H
Histol Histopathol; 2018 Sep; 33(9):937-949. PubMed ID: 29608014
[TBL] [Abstract][Full Text] [Related]
26. The importance of integrin-linked kinase in the regulation of bladder cancer invasion.
Matsui Y; Assi K; Ogawa O; Raven PA; Dedhar S; Gleave ME; Salh B; So AI
Int J Cancer; 2012 Feb; 130(3):521-31. PubMed ID: 21351095
[TBL] [Abstract][Full Text] [Related]
27. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
[TBL] [Abstract][Full Text] [Related]
28. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
29. Integrin-linked kinase regulates cadherin switch in bladder cancer.
Gil D; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Laidler P
Tumour Biol; 2016 Nov; 37(11):15185-15191. PubMed ID: 27683053
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells.
Fuchs BC; Fujii T; Dorfman JD; Goodwin JM; Zhu AX; Lanuti M; Tanabe KK
Cancer Res; 2008 Apr; 68(7):2391-9. PubMed ID: 18381447
[TBL] [Abstract][Full Text] [Related]
31. Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma.
Schaeffer DF; Assi K; Chan K; Buczkowski AK; Chung SW; Scudamore CH; Weiss A; Salh B; Owen DA
Virchows Arch; 2010 Mar; 456(3):261-8. PubMed ID: 20091050
[TBL] [Abstract][Full Text] [Related]
32. Role of the integrin-linked kinase (ILK)/Rictor complex in TGFβ-1-induced epithelial-mesenchymal transition (EMT).
Serrano I; McDonald PC; Lock FE; Dedhar S
Oncogene; 2013 Jan; 32(1):50-60. PubMed ID: 22310280
[TBL] [Abstract][Full Text] [Related]
33. Identification of a Small Molecule That Selectively Inhibits ERG-Positive Cancer Cell Growth.
Mohamed AA; Xavier CP; Sukumar G; Tan SH; Ravindranath L; Seraj N; Kumar V; Sreenath T; McLeod DG; Petrovics G; Rosner IL; Srivastava M; Strovel J; Malhotra SV; LaRonde NA; Dobi A; Dalgard CL; Srivastava S
Cancer Res; 2018 Jul; 78(13):3659-3671. PubMed ID: 29712692
[TBL] [Abstract][Full Text] [Related]
34. Effects of lentivirus-mediated shRNA targeting integrin-linked kinase on oral squamous cell carcinoma in vitro and in vivo.
Que L; Zhao D; Tang XF; Liu JY; Zhang XY; Zhan YH; Zhang L
Oncol Rep; 2016 Jan; 35(1):89-98. PubMed ID: 26531674
[TBL] [Abstract][Full Text] [Related]
35. Functional consequences of integrin-linked kinase activation in podocyte damage.
Teixeira Vde P; Blattner SM; Li M; Anders HJ; Cohen CD; Edenhofer I; Calvaresi N; Merkle M; Rastaldi MP; Kretzler M
Kidney Int; 2005 Feb; 67(2):514-23. PubMed ID: 15673299
[TBL] [Abstract][Full Text] [Related]
36. PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase.
Li Y; Dai C; Wu C; Liu Y
J Am Soc Nephrol; 2007 Sep; 18(9):2534-43. PubMed ID: 17656471
[TBL] [Abstract][Full Text] [Related]
37. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
38. ILK expression in human basal cell carcinoma correlates with epithelial-mesenchymal transition markers and tumour invasion.
Papanikolaou S; Bravou V; Gyftopoulos K; Nakas D; Repanti M; Papadaki H
Histopathology; 2010 May; 56(6):799-809. PubMed ID: 20546345
[TBL] [Abstract][Full Text] [Related]
39. ERG deregulation induces PIM1 over-expression and aneuploidy in prostate epithelial cells.
Magistroni V; Mologni L; Sanselicio S; Reid JF; Redaelli S; Piazza R; Viltadi M; Bovo G; Strada G; Grasso M; Gariboldi M; Gambacorti-Passerini C
PLoS One; 2011; 6(11):e28162. PubMed ID: 22140532
[TBL] [Abstract][Full Text] [Related]
40. Abnormal expression of the ERG transcription factor in prostate cancer cells activates osteopontin.
Flajollet S; Tian TV; Flourens A; Tomavo N; Villers A; Bonnelye E; Aubert S; Leroy X; Duterque-Coquillaud M
Mol Cancer Res; 2011 Jul; 9(7):914-24. PubMed ID: 21669963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
